التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
التداول ينطوي على مخاطر
الاستثمارات تنطوي على مخاطر وليست مناسبة لجميع المستثمرين. العقود مقابل الفروقات هي أدوات معقدة وتنطوي على مخاطر عالية لخسارة الأموال بسرعة بسبب الرافعة المالية.
Agilent Technologies Inc
Closed
Sector Healthcare
133.84 1.34
Overview
Share price change
24h
Min
133.49
Max
134.29
Income | 282M |
|---|---|
Sales | 10M 1.6B |
P/E Sector Avg | 33.51 94.998 |
EPS | 1.32 |
Dividend yield | 0.668 |
Profit margin | 17.848 |
EBITDA | -29M 428M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +14.32 upside |
Dividend yield Sector Avg | 0.67% 2.40% |
|---|---|
Next Earnings | ٢٥ نوفمبر ٢٠٢٤ |
Next Dividend date | ٢٢ يناير ٢٠٢٥ |
Next Ex Dividend date | ٣١ ديسمبر ٢٠٢٤ |
Market Cap | -2.8B 37B |
|---|---|
Previous open | 132.5 |
Previous close | 133.84 |
News Sentiment
By Acuity
57%
43%
318 / 392 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Agilent Technologies Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Agilent Technologies Inc Forecast
Price Target
By TipRanks
14.32% upside
12 Months Forecast
Average 153 USD 14.32%
High 165 USD
Low 145 USD
Based on 5 Wall Street analysts offering 12 month price targets forAgilent Technologies Inc - Dist in the last 3 months.
Sentiment
By Acuity
318 / 392 Ranking in Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
